Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced that the European Medicines Agency's Committee for Orphan Medicinal Products has adopted a positive ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA